Management of intestinal failure in Europe. A questionnaire based study on the incidence and management by Staun, Michael et al.
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
Dynamic Medicine
Open Access Research
Management of intestinal failure in Europe. A questionnaire based 
study on the incidence and management
Michael Staun*1, Xavier Hebuterne2, Jon Shaffer3, Kent V Haderslev1, 
Frederico Bozzetti4, Marek Pertkiewicz5, Ann Micklewright6, Jose Moreno7, 
Paul Thul8 and Loris Pironi9
Address: 1Department of Medical Gastroenterology, Rigshospitalet, Copenhagen, Denmark, 2Department of Gastroenterology and Clinical 
Nutrition, Archet University Hospital, Nice, France, 3Intestinal Failure Unit Hope Hospital, Salford, UK, 4Department of Surgery, Hospital of Prato, 
Prato, Italy, 5Department of Nutrition and Surgery, W. Orlowski University Hospital, Warsaw, Poland, 6University Hospital, Queen's Medical 
Centre, Nottingham, UK, 7Department of Nutricion Clinica Y Dietetica, Hospital 12de Octobre, Madrid, Spain, 8Department of Surgery, Charité 
University Hospital, Berlin, Germany and 9Department of Internal Medicine and Gastroenterology, Center for Chronic Intestinal Failure, St. 
Orsola-Malpighi Hospital, Bologna, Italy
Email: Michael Staun* - Staun@rh.dk; Xavier Hebuterne - Xavier.Hebuterne@unice.fr; Jon Shaffer - jon.shaffer@srht.nhs.uk; 
Kent V Haderslev - khaderslev@dadlnet.dk; Frederico Bozzetti - dottfb@tin.it; Marek Pertkiewicz - pertek@amwaw.edu.pl; 
Ann Micklewright - ann.micklewright@mail.qmcuh-tr.trent.nhs.uk; Jose Moreno - jmoreno.hdoc@salud.madrid.org; 
Paul Thul - paul.thul@charite.de; Loris Pironi - pironi@med.unibo.it
* Corresponding author    
Abstract
Background:  Intestinal failure is the outcome of a number of gastrointestinal diseases and
characterized by significant reduction in functional gut mass. If not resolved patients often face long-
term nutritional support. This study gathered information about how patients referred with
intestinal failure are managed in specialised European centres.
Methods: A questionnaire was circulated in 7 European countries via representatives of the
ESPEN-HAN working group to seek information about experience in treating patients with
intestinal failure. We asked about clinical outcome, information about structure and organisation
of the department, referral criteria, treatment procedures and guidelines.
Results: 17 centres in 6 European countries completed the questionnaire: UK, n = 6, France, n =
4, Spain, n = 3, Denmark, n = 2, Italy, n = 1, Poland, n = 1. The experience of the centres in treating
patients was in the range 12–30 years. The total number of patients on HPN in all centres was 590.
The number of patients referred to centres with intestinal failure during the period January to
December 2000 was n = 882: UK, n = 375 (range 2–175), France, n = 308 (range 24–182), Italy and
Spain, n = 43 (range 9–52), Denmark n = 51 (range 14–37), the centre in Poland included 53
patients. Comparing all centres the following distribution among patients (median % (range%)) with
regard to the endpoints were reported: Oral nutrition 32% (23–50%), enteral/tube feeding 11% (4–
23%), HPN 36% (15–57%), lost to follow up 10% (0–35%), dead 9% (5–18%). No patients had an
intestinal transplant.
Conclusion:  The study provides information about how patients with intestinal failure are
managed across Europe and the data indicates that treatment practice varies between countries.
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Background
Intestinal failure is defined by a reduction in the func-
tional gut mass to the level that the patient depends on
parenteral supply of nutrients, water and electrolytes to
survive [1]. The condition is not an uncommon endpoint
for a variety of diseases including Crohn's disease, compli-
cations following surgery, mesenteric vascular disease and
radiation enteritis [2-4]. Intestinal decompensation may
resolve quickly or persist as a chronic condition and the
patient may then face long-term nutritional support [5,6].
Most often, patients or relatives are trained to manage
procedures and treatment can then be offered in the home
as home parenteral nutrition (HPN).
The studies of the ESPEN-HAN Working group and others
have provided knowledge about the indication, inci-
dence, prevalence and the prognosis of patients managed
on home parenteral nutrition [7,8]. However, data on the
incidence and prevalence as well as management of
patients with intestinal failure, from which the HPN-
group generally is recruited, are rather scarce and little is
known about the outcome of these patients. Clinically,
patients with intestinal failure cannot be fed by enteral
route due to intestinal complications or active disease and
most patients need parenteral nutritional supply. The
indication for referral to specialised centres is specific clin-
ical problems such as assessment of short bowel, manage-
ment of fistula or sepsis, venous access problems and the
need of specialised abdominal surgery.
The aim of the present study was to obtain information
about how centres in Europe manage patients with intes-
tinal failure. Using a questionnaire, we gathered informa-
tion about experience, structure and organisation of the
departments involved, about specific aspects of treatment
procedures, existing guidelines, referral criteria, and final
outcome for patients with intestinal failure.
Methods
The design of the questionnaire
The ESPEN-HAN Working group designed the question-
naire for the study. The questions covered the following:
Experience with treatment of these patients, including
number of years with experience on home parenteral
nutrition. Also, we asked for information about the
number of patients referred during the year 2000 and
information about endpoints of treatment, enteral nutri-
tion, parenteral nutrition and length of stay in the hospi-
tal. Furthermore, we collected information about the
structure of the department with relation to treatment of
patients with intestinal failure, the number of beds for
management of intestinal failure, the presence of a nutri-
tion team and specialized teams for management of cen-
tral lines, experience with intestinal transplantation and
research within in this specific group of patients. The pat-
tern of referral of these patients was also investigated as
well as the level of information available to referring
departments. Furthermore, departments were asked about
treatment procedures, education of personnel in the man-
agement of intestinal failure and we asked for information
about written guidelines.
The selection of centres for the study
This study was carried out in selected centres, defined as
centres with a special interest and experience in the man-
agement of these patients, but no specific criteria for the
selection of centres were defined. Thus, the questionnaire
was circulated to the centres through the individual
ESPEN-HAN group members of the European countries. A
covering letter describing the purpose of the study was
sent to each centre from the ESPEN-HAN group member.
Statistics
All data are givens as median and range unless otherwise
indicated.
Results
Centres and patients
Table 1 shows the number of centres in each country
invited to participate in the investigation, the number of
responders and the total number of patients referred with
intestinal failure during the study period from January 1st
to December 31st 2000. A total of 23 centres across Europe
were invited to participate and 17 responded. These cen-
tres reported that a total of 882 patients were referred dur-
ing the period of investigation. For the previous year of
1999 centres reported a total number of 564 referred with
intestinal failure.
Structure and experience of centres
Centres answered that the total number of beds reserved
solely for treatment of intestinal failure were 111, and
within each country the number of beds ranged from 0–
42. Centres had a mean experience of 16 years (range 12–
30) in the management of patients with intestinal failure
and currently had 590 patients on HPN due to chronic
intestinal failure. Of the centres, 33% were specialised in
medical gastroenterology, 33% in surgical gastroenterol-
ogy and 33% had both disciplines within the same unit.
Of the centres 5 (29%) answered that they were engaged
in research projects within this field. One centre had expe-
rience with intestinal transplantation, 3 centres (17%)
answered that they had some experience with this proce-
dure, and the remaining 76% had no experience with
intestinal transplantation. Table 2 shows the total number
of physicians and nurses involved in the treatment of
these patients in all centres. Table 3 shows the number of
hours spent per week by doctors and nurses on the task of
taking care of patients with intestinal failure. The table
indicates that there are significant differences in how theDynamic Medicine 2007, 6:7 http://www.dynamic-med.com/content/6/1/7
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treatment of these patients is organized. The number of
hours spent per week by doctors for each country ranged
from 22 to 375 and was not related to the number of beds
assigned for this treatment. When comparing time spent
per bed the range was broad for both nurses and physi-
cians.
Referral of patients and organization of treatment
The centres were asked if they believed that all patients
diagnosed with intestinal failure were being referred for
treatment when required. Two centres (11%) in Spain and
Poland reported that all patients were referred. Of the cen-
tres n = 8 (47%) were of the opinion that more than 75%
of patients were referred for treatment and 2 centres
(11%) in France and Spain answered that they believed
that no more than 50% of patients were being referred for
treatment. Five centres (31%) in the UK and Denmark
were not sure what to answer.
Centres were asked about pattern of referral criteria, geo-
graphical and speciality. Centres were allowed more than
one answer. Of the centres, 11 had patients referred from
the region, 7 centres received patients referred more ran-
domly. The departments of abdominal surgery referred
the majority of patients for treatment. All centres except
one received patients from this speciality and 7 centres
received patients from departments of medical gastroen-
terology. Of the 17 centres, 4 (24%) were reimbursed for
their services and 6 (34%) centres had a waiting list.
Centres were asked if they believed that the treatment of
intestinal failure was well organized in their country or
region. Of the centres, 35% reported that treatment was
well organized and 65% answered that organization
needed improvement.
Referral criteria
Departments were asked if a specific set of referral criteria
were used and if so, we asked who had defined these cri-
teria. Of the centres 7 (41%) reported to adhere to guide-
lines of referral defined by the department or the hospital.
Information about the service provided to referring 
departments
With regard to the treatment of intestinal failure, centres
were asked if the clinical director/head of department ini-
tiated activities to inform about the experience and 'know
how' of the department. Specific questions asked for
workshops about management of intestinal failure at the
institution, if the 'know how' were accessible on a web site
and whether any written information about the unit was
available on demand. Of the centres 8 (47%) answered
that the head of department took initiatives to inform
about the service provided and 5 centres (29%) reported
that workshops were being held on intestinal failure man-
agement. In 7 (41%) centres written information was
available on request.
Table 2: Number of physicians and nurses involved in treatment of intestinal failure in each country.
Physicians Nurses
Country n % of total staff n % of total staff
U K 9 2 43 64 9
F r a n c e 8 2 21 52 0
I t a l y 1334
S p a i n 1 02 71 21 6
Poland 4 11 2 3
Denmark 5 14 6 8
Total 37 74
Table 1: Number of centres invited, number of responding centres and the number of patients referred with intestinal failure in 2000.
Country Number of centres invited Number of centres that 
responded
Patients referred with intestinal failure from 
January to December 2000
UK 8 6 375
France 6 4 308
Italy 1 1 52
Poland 1 1 53
Spain 6 3 43
Denmark 2 2 51
Total 23 17 882Dynamic Medicine 2007, 6:7 http://www.dynamic-med.com/content/6/1/7
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Guidelines
We asked for information about written guidelines on
treatment of intestinal failure in general and guidelines
for parenteral and enteral nutrition. Of the responders, 5
centres (29%) had written guidelines on how to manage
intestinal failure. All centres except one had guidelines for
parenteral nutrition and 13 (76%) had guidelines for
enteral nutrition. With regard to management of intesti-
nal failure, we asked more specifically for information
about guidelines on some of the most frequent complica-
tions and clinical difficulties associated with this clinical
condition: sepsis and catheter related sepsis, fistula man-
agement, high output stoma, vein thrombosis and liver
disease. The results are shown in Table 4.
Length of hospital stays for patients with intestinal failure
Table 5 shows the median and range of the length of the
hospital stay. Data are pooled for each of the countries
involved in the study.
The endpoints of treatment of intestinal failure
Centres were asked for data on endpoints of treatment for
patients admitted during the period January 1st to Decem-
ber 31st 2000, and discharged before December 31st 2000.
The following endpoints were considered: Discharged
from hospital with oral or enteral nutrition or tube feed-
ing and HPN. Also we asked for data on death rate, intes-
tinal transplantation performed and whether patients
were lost to follow up. Table 6 shows the main results for
all centres with regard to endpoint of treatment. The table
was compiled by the inclusion of data from all centres.
Discussion
Seventeen out of 23 centres responded and a possible bias
is that centres with a known expertise may not have been
asked to participate or may not have responded and this
should be considered when evaluating the data. Data are
representative in the sense that information was obtained
from across Europe involving 17 centres in 6 countries
and the survey includes about 900 patients diagnosed
with intestinal failure. The number of centres in each
country varied significantly and was not correlated to
number of inhabitants, but more likely reflects the organ-
ization of treatment of these patients on a national level.
Epidemiological data about the prevalence or incidence of
intestinal failure in adults or children are not available.
This possibly reflects that the clinical entity has a low prev-
alence with a multifactorial aetiology. In addition, criteria
for this diagnosis have never firmly been agreed upon. The
prevalence of home parenteral nutrition has been
reported, but these data do not include patients with
intestinal failure with a temporary need for parenteral
support. Surveys on HPN in Europe indicated an inci-
dence of 2–3 patients per million and the prevalence was
reported to about 4 per million with a broad range [7,8].
No studies on prevalence and incidence of HPN in Europe
have been published recently since the organisation of
this service in many countries has changed from being
Table 4: Number of centres with written guidelines for management of guidelines for complications/clinical issues associated with 
intestinal failure.
Complication n % of all
Sepsis 12 71
Fistula 3 18
Catheter related sepsis 17 100
Catheter related venous thrombosis 10 59
High output stoma 9 53
Liver disease 3 18
Table 3: Resources used by nurses and physicians reported by centres as hours per week.
Physician Nurse
Country Number of beds for ITF treatment Hours/week % Of total Hours/week/bed Hours/week % Of total Hours/week/bed
UK 42 22 3 0.52 1325 59 31.5
France 29 151 21 5.2 169 8 5.8
Italy 2 24 3 12.0 3 0 1.5
S p a i n 0 3 7 55 1 - 4 6 92 1 -
Poland 0 54 7 - 48 2 -
Denmark 38 105 14 2.7 218 10 5.7
Total 111 731 2232Dynamic Medicine 2007, 6:7 http://www.dynamic-med.com/content/6/1/7
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centralised. In the US larger figures have been reported
possibly reflecting that the indication for this treatment
differs between continents [9,10]. The organizational
structure of HPN in Europe has changed in the last few
years but the most recent survey does not provide data
that can be used for calculation of prevalence and inci-
dence of HPN on a national level, at least only in some
countries (11). This makes it even more difficult to esti-
mate epidemiological data for intestinal failure since a
varying number of patients are unaccounted for, as in this
study, or may be weaned off parenteral nutrition before
entering HPN programs. In keeping with this, Messing et
al. [5] reported that as many as 27% of patients with short
bowel syndrome were off parenteral nutrition one month
after the event that caused intestinal failure.
The survey confirms that patients with intestinal failure
stay in hospital for significant amount of time, hence, up
to 700 days in a UK centre, and the median length of stay
ranges between 17 in Italy and 228 in Denmark. This is
not surprising; intestinal failure is often associated with a
number of additional clinical problems such as high out-
put stoma, fistula, sepsis and liver and kidney failure and
patients may need specialized treatment for a long period.
We are not aware of previous data on length of stay for
this group of patients.
The large variation in mortality rate reported between
countries could be related to a greater number of cancer
patients being treated in some centres. Surveys in Europe
have shown that cancer is a more common indication for
HPN in the southern part of Europe [11].
The clinical challenge is to re-establish intestinal function
whenever possible so that patients with intestinal failure
can be managed on oral or enteral nutrition. In this study
we found that about 43% of the patients could be send
home on oral or enteral nutrition. About on third of the
patients were discharged from hospital with parenteral
nutrition. Interestingly, none of the centres had referred
patients for intestinal transplantation procedures in
accordance with a recent study on the indication for intes-
tinal transplantation showing that European centres have
some reluctance to refer patients for this procedure [12].
Experience of the centres participating in this study varies
significantly, but all centres had an experience of 12 years
or beyond and were handling a considerable amount of
patients with chronic intestinal failure maintained on
HPN. Management of patients with intestinal failure in
many cases requires a close collaboration between surgi-
cal and medical gastroenterology and the centres reported
that patients were treated either in the individual special-
ity or in a unit with access to both disciplines. Resources
in terms of time spent on these patients by nurses and
physicians showed considerable variation with the high-
est values reported for both nurses and physicians
reported in the UK and Denmark. In the UK, intestinal
failure units have been established and in Denmark treat-
ment of intestinal failure patients has been assigned to
very few centres.
We asked for information about referral of patients with
intestinal failure and the answers were diverging. Only
10% of centres were of the opinion that all patients were
Table 6: The endpoints of treatment of intestinal failure for all patients in the study.
Median (%) Range (%)
Oral nutrition 32 23–50
Enteral nutrition/tube feeding 11 4–23
HPN 36 15–57
Died 9 5–18
Intestinal transplantation performed 0 0
Lost to follow up 10 0–35
Table 5: Length of hospital stays.
Median (days) Range (days)
UK 79 2–700
France 71 1–210
Italy 17 5–93
Spain 85 10–150
Poland 25 9–86
Denmark 228 7–360Dynamic Medicine 2007, 6:7 http://www.dynamic-med.com/content/6/1/7
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being referred, but close to 60% of the centres in different
countries were quite certain that no more than 50–75% of
the intestinal failure patients were being referred for treat-
ment. The results indicate that treatment is not well organ-
ized in all countries and that may not even be the case in
countries with a set of national guidelines for treatment.
This is also reflected in the referral pattern, patients are
reported coming from both the region in which the centre
is placed and patients are also sent from other depart-
ments. Although centres did not believe that all patients
were referred for treatment about one third had a waiting
list. The majority of centres were of the opinion that treat-
ment could be better organized.
Guidelines for treatment of intestinal failure have not
been developed in all centres and only 29% reported that
such guidelines were available. With regard to specific
treatment with enteral and parenteral nutrition, the
majority of centres had guidelines. The management of
the most common complications related to intestinal fail-
ure was also described in guidelines supporting that cen-
tres generally were highly specialised in taking care of
these patients.
Conclusion
This study indicates that patients with intestinal failure are
being managed across Europe in specialised units in the
setting of both surgical and medical gastroenterology; the
organizational structure of this service varies significantly
between centres. The study reports on about 900 patients
diagnosed with this diagnosis and shows that about 43%
are discharged with per oral or enteral nutrition and 36%
with parenteral nutrition. Mortality rate during a one-year
observation period is about 10% and no patients were
referred for intestinal transplantation. Not all patients are
referred for treatment and not all centres have specific
guidelines for management of intestinal failure, although
they in general have much experience. More information
about epidemiology of intestinal failure can provide a bet-
ter understanding of disease impact. This study does not
provide details about outcome and prognosis in relation
to primary disease and complications; this would require
a prospective study in selected centres.
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Appendix
We are indebted to contributors to HPN survey in Europe,
(see Table 7).
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